AGP Executive Report
Last update: 6 hours agoUS–Liechtenstein Pharma Trade: The US Commerce Department has listed Liechtenstein (along with 19 other jurisdictions) for a 0% ad valorem tariff on select specialty medicines and key ingredients, even as a broader 100% tariff on certain patented drugs starts for other companies from 29 September; the zero-duty categories include orphan drugs, infertility treatments, cell and gene therapies, antibody-drug conjugates, and some medical countermeasures, with eligibility tied to specific trade/security frameworks. EU Digital Identity: After 20 years, the .eu domain is framed as everyday European infrastructure, with the choice of a European top-level domain seen as a signal of community rather than a technical upgrade. Market Watch (Furniture): Europe’s upholstered furniture sector remains highly fragmented, with concentration slowly rising and Liechtenstein-based Cotta Collection among the notable manufacturers by market share. Cross-border Trade (EFTA–India): India and EFTA will review the TEPA trade pact at a summit in October, aiming to tackle market-access and procedural bottlenecks as exports to the bloc have fallen. Local/Regional Context: A separate report notes relaxed staffing rules in healthcare to ease shortages, relevant for services and workforce planning.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
